After taking the helm at Biogen (NSDQ:BIIB) in 2016, Michel Vounatsos made use of acquisitions and geographic expansion to grow the company. Now, Vounatsos is reportedly considering another possible opportunity to differentiate the pharmaceutical player.
The company’s chief executive hinted in an interview with Globes that Biogen could make a move into the medical technology space.
Get the full story at our sister site, Drug Delivery Business News.
The post Report: Biogen CEO eyes medical device market appeared first on MassDevice.